Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
trxc - CFO exercised 200K warrants at $1.00. Kept shares.
http://ir.transenterix.com/secfiling.cfm?filingID=1209191-17-56991&CIK=876378
thx re AGN. I thought it was overdone so took off the weekly puts that I sold. Just closed them out based upon your perspective. Enough to fund my latte habit for the year. I expect volatility to continue and I also think that AGN are hiding some defenses to protect an important market.
Thx. What's your worse case scenario for margin erosion and market share loss for AGN?
It will depend on what they say about sales tomorrow.
Buying opp?
It will sell because of the much lower cost per procedure for essentially the same capability of the Da Vinci Si. The question is how much market share they take. Shares and ATM plus warrants takes this up to around 220M. One billion market cap would put this at 4+ if there is any indication that systems sales are in the pipeline.
Some numbers on the economics of small electric planes compared to small conventional planes. Training and hobby costs are going to come way down.
"Where the 4-seater innovates further is with a total operating cost per hour of $19.80, compared to $122/hour for a Cessna 182. It will use the same cabin and wingspan, but reduces the wing area to 120 sq. ft. and the glide ratio comes down to 18.7. The crew and passenger weight almost doubles to 800 lb, with a gross weight of 2,700 lb."
https://cleantechnica.com/2017/10/14/electric-sun-flyer-4-goes-two-four-seats/
Good to see that they have a process to improve the work force. Hundreds out of 33,000 annually seems low actually. Exxon as an example had a process to trim the 5% of their work force annually through performance reviews and attrition.
TRXC - +80% AH on FDA 510k clearance. Ahead of schedule that I anticipated.
"FDA concluded that these study data, supported by real-world evidence, along with performance testing under simulated use and worst-case scenario conditions, demonstrated the substantial equivalence of the Senhance System to the da Vinci Si IS3000 device for gynecological and colorectal procedures."
TRXC - +80% AH on FDA 510k clearance. Ahead of schedule that I anticipated.
"FDA concluded that these study data, supported by real-world evidence, along with performance testing under simulated use and worst-case scenario conditions, demonstrated the substantial equivalence of the Senhance System to the da Vinci Si IS3000 device for gynecological and colorectal procedures."
plse - Quite a bounce, almost doubled, since news of 510K application withdrawal a month ago. Resubmittal with requested data must be a slam dunk.
Looked it up. Buyer was NEA, VC firm on Sand Hill. Looks like the one of the Sonsini sons (Larry Sonsini of Wilson Sonini fame)
I wonder if this was the BOD nominee of the private placement buyer from 4 months ago. Who was the buyer?
No idea whether it is just technical or whether there is something positive to be anticipated from upcoming readouts. Volume has been miniscule so volatility is to be expected.
Yes, our Arab "friends" are trying hard to make sure their gas reserves are worth something instead of being stranded. Maybe they will be the ones to build the H2 infrastructure for the world and just for Toyota to play with. Come to think of it, now that solar bids in the middle east are below 3 cents/kwh, they can use all that cheap solar to generate H2 and ship it all over the world. LOL
TRIL - appointment of ADAP exec to BOD today.
https://www.sec.gov/Archives/edgar/data/1616212/000106299317004378/exhibit99-1.htm
Alexo's inhibitor sounds similar to 622 and tril-investor give them about the same odds(he gave 622 one extra star) so there should be some implications from Alexo's P1 readouts?
Optimising field operations via SCADA has been around a while. Hard to tell from the article how big of an incremental improvement will result with the addition of AI without any details. Links to some technical articles with real case studies would have been nice.
@tril_investor is "very long" in his own words and I wonder about the objectiveness of his summary. If the other approaches are so inferior with the exception of novimmune, why would others spend so much pursuing them when all they have to do is get a stake in Tril? Comments appreciated.
btw - i have a lottery ticket sized allocation so my wish is that he is absolutely objective but we are human.
From their release in July (my bad on Aug as that's what I wrote before)
----------
The Series AAA warrants have an exercise price of $2.07 per share, are initially exercisable six months following issuance, and terminate five and one-half years following issuance. The Series BBB warrants have an exercise price of $4.75 per share, are immediately exercisable, and terminate one year following issuance.
----------
Denmark - DONG (Danish Oil and Gas) changes name to Orsted as it transitions rapidly to renewables, mostly wind for now. Denmark has been self sufficient O&G producer since the 1990s.
https://www.greentechmedia.com/articles/read/dong-energy-changes-name-while-dropping-fossil-fuels
clsn - They did a raise back in August for $5M at 2.07 that came with 2.45M warrants exercisable at the same price months post raise. And another 2.45M warrants exercisable at 4.75 immediately. So outstanding shares+warrants is around 14.5M. They now have some flexibility to shore up finances if rebound in share prices stick.
The market cap does seem small but I haven't look at share/warrants structure.
I thought Toyota is finally going to get their head out of the sand but it is a big company and there are still silos that hope that non-EVs are the answer. China had their first crackdown on subsidy abuse last year and it did impact sales, for the first month when implementation started!
http://www.scmp.com/business/companies/article/2019315/crackdown-electric-vehicle-subsidy-cheats-expected-favour
http://www.ev-volumes.com/country/china/
PS I attended years ago a discussion by an E level integrated oil company. A side topic to work with TM on providing a betA network of H2 refueling stations was chatted about. That was going to be the transition to sustainable energy. Things change, ideas change. Nobody believed solar can drop below 3 cents/kwh and that battery cost goes down 17%/year. Sheik Yamani's wisdom is being witnessed now. The only question is the time frame.
I agree with a smidgen of the generalities you wrote about but I won't touch TITXF given their track record on promises. Example linked below.
http://www.titanmedicalinc.com/wp-content/uploads/2014/02/Seeking-Alpha-PRO-Article-Early-Look-for-Subscribers-Seeking-Alpha.pdf
Who is adventurous enough to providing the H2 infrastructure? Pls. elucidate.
I assume you are referring to Titan. They have been at it a long time and still gathering data on animals. ISRG has single port in r&d for several years now and still haven't pushed it out. Is going through one hole at the belly button really better surgery? Perhaps there is some advantage for GYN. Pls provide details from your perspective.
How high do you think the roof is? Option MM has priced in ~10% chance of exceeding 7.5 by Nov expiration but that probably has low weight given the illiquidity of both shares and options currently.
Toyota at it again. I think the Murai looks like a Camry after an allergic reaction. I have seen a couple around. The owners must drive by the H2 station on a regular basis because there is only one station within 40 miles of where I live.
PLSE +24% on the private placement news. I would love to know what data the FDA asked for. On the PLSE website, they provide a summary of preclinical studies on the effect of electroporation on tumors and immune response. Could the FDA be asking for clinical data via randomised studies? It would be fantastic if it works but it seems a lot of work lays ahead to prove it.
http://www.pulsebiosciences.com/major-discoveries/
Did you include the annual cost of enforcing the Carter Doctrine? Last time I checked it was $700/citizen annually.
Any thoughts on the changes between original planned dosing filed 9/16 and the change filed on 5/17?
>>>
EDP 305 Dose 1, Dose 2, Dose 3, Dose 4 and Dose 5, oral suspension, once daily in one single administration
change - EDP 305 Dose 1, Dose 2, Dose 3, Dose 4, Dose 5, and Dose 6 oral suspension, once daily in one single administration
>>>
EDP 305 Dose 1, Dose 2 and Dose 3, oral suspension, once daily for 14 days
change - EDP 305 Dose 1, Dose 2, Dose 3, Dose 4, Dose 5 and Dose 6 oral suspension, once daily for 14 days
trxc Senhance platform is going through 510k process. The usual time frame after the response letter is 30-60 days. It is ce marked and has 20 installations, most of them in EU. One in Florida hospital for their r&d program. 510k clearance will result in US sales no doubt. How well the system sells in the US post clearance is open question since isrg has the market. Senhance competes by allowing existing lap devices to be used with it which is a plus and much more economical than the proprietary tools that one has to use with Da Vinci. SYK and NVDQ can be used with Senhance as examples. IMO haptics is important and something Da Vinci does not have yet. The other platform that they have worked on is a single port robotised version of their spider lap system called Surgibot. That was rejected in the past because the FDA ruled that it is too different than the spider to go through the 510k route. isrg is also worked on single port robot and I haven't looked into the stasis of that.
APC's CFO is better at trading than I am for sure. There was an article (Bloomberg?) today about the widening discount in terms of EV/ebita between XOM and APC, and how that makes APC more attractive shark bait. I think the discount is there for a reason, XON has big ballast in refining and chemicals. If current trends continue, upstream and downstream will flip-flop back to decades of old when oil refiners make most of the money during an era of surplus.
trxc - gap fills as expected. Post 9/18 PR that company has filed early response to FDA AI request letter as part of 510k review process. 30 day clock starts upon FDA receipt of response.
Barron's bearish analyst write up.
http://www.barrons.com/articles/tesla-apple-and-amazon-alike-in-spirit-not-profits-1505848745?mod=hp_Next&
He does have a valid point assuming that Musk has a Detroit business model. Question for the bears is "Will he?" Such linear thinkers on WS will be great running F and GM.
Mercedes taking deposits on GL suv EV in Norway.
https://bilkjop.mercedes-benz.no/eq-reservasjon/
"TSLA is NOT a tech company, they are a car company" Hmmm have to think about the conjugate which is "we are a car company, not a tech company". In that case, it will be very easy for the Detroit boys to get their act together since they are there already.
Could be. Below link shows side by side comparison with August model. I have not seen a rapid change like this in the past. Scrolling down to the second set of figures suggest Sept forecast averages fewer models. If we take only the NASA forecast, things really didn't change much. Also, one is a 3-month moving average and the other is monthly. Is someone at Columbia (not to be confused with CPC/NOAA) trading ngas?
http://iri.columbia.edu/our-expertise/climate/forecasts/enso/current/
What reasons do you think TSLA has to do ANY deal with Ballard? I haven't looked at Ballard in ages so pls tell me what's there now.
CHK - Barron's explanation of the rise in CHK is increasing probability of La Nina and cold winter season. Up to 55% chance of La Nina. I don't see it from NOAA's CPC expert consensus. Hasn't changed for the last few updates. see slide 23
http://www.cpc.ncep.noaa.gov/products/analysis_monitoring/lanina/enso_evolution-status-fcsts-web.pdf